Filtros de búsqueda

Lista de obras de

A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

article

A comparison of bilateral breast cancers in BRCA carriers

artículo científico publicado en 2005

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.

artículo científico publicado en 2012

A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients

artículo científico publicado en 2005

A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

artículo científico publicado en 2012

A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity

artículo científico publicado en 2004

A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer

scientific article published on 01 January 2003

AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study

artículo científico publicado en 2007

Adaptive Randomization of Neratinib in Early Breast Cancer

artículo científico publicado en 2016

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer

artículo científico publicado en 2016

Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium

artículo científico publicado en 2014

Adoption of Gene Expression Profiling for Breast Cancer in US Oncology Practice for Women Younger Than 65 Years

artículo científico publicado en 2015

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

article

Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

article

Alcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristics

artículo científico publicado en 2014

Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results

artículo científico publicado en 2002

An exercise trial to reduce cancer related fatigue in African American breast cancer patients undergoing radiation therapy: Design, rationale, and methods

artículo científico publicado en 2016

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

artículo científico publicado en 2015

Analysis of co-aggregation of cancer based on registry data

artículo científico publicado en 2006

Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results

artículo científico publicado en 2014

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

artículo científico publicado en 2016

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

artículo científico publicado en 2010

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901.

artículo científico publicado en 2014

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis.

artículo científico publicado en 2017

Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis.

artículo científico publicado en 2018

BRCA mutation testing in determining breast cancer therapy

artículo científico publicado en 2011

BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry

artículo científico publicado en 2019

BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study

scientific article published on 03 October 2020

BRCA1/2 mutations and triple negative breast cancers

scientific article published on January 2010

BRCA1/2 test results impact risk management attitudes, intentions, and uptake

artículo científico publicado en 2010

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

artículo científico publicado en 2015

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

artículo científico publicado en 2004

Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.

artículo científico publicado en 2007

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing

scientific article published on 01 November 2003

Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States

artículo científico publicado en 2016

Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers

artículo científico publicado en 2012

Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer

artículo científico publicado en 2002

Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians

artículo científico publicado en 2010

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

artículo científico publicado en 2005

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

artículo científico publicado en 2016

Breast cancer-related pseudocirrhosis and esophageal varices

artículo científico publicado en 2005

Cancer variation associated with the position of the mutation in the BRCA2 gene

artículo científico publicado en 2004

Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study

artículo científico publicado en 2007

Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study

article

Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines

artículo científico publicado en 2016

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2005

Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials

artículo científico publicado en 2017

Characterization of BRCA1 and BRCA2 mutations in a large United States sample

artículo científico publicado en 2006

Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

artículo científico publicado en 2020

Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort

artículo científico publicado en 2010

Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib.

artículo científico publicado en 2017

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

artículo científico publicado en 2009

Clinically relevant changes in family history of cancer over time

artículo científico publicado en 2011

Coffee consumption and breast cancer risk amongBRCA1 andBRCA2 mutation carriers

article

Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).

artículo científico publicado en 2017

Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?

artículo científico publicado en 2014

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy

artículo científico publicado en 2012

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction

artículo científico publicado en 2010

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

artículo científico publicado en 2011

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2008

Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers

artículo científico publicado en 2011

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

artículo científico publicado en 2012

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

artículo científico publicado en 2011

Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium

artículo científico publicado en 2010

Conveying genomic recurrence risk estimates to patients with early-stage breast cancer: oncologist perspectives

artículo científico publicado en 2013

Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers

artículo científico publicado en 2019

Cost Effectiveness of Gene Expression Profile Testing in Community Practice.

artículo científico publicado en 2018

Deleterious BRCA1/2 mutations in an urban population of Black women.

artículo científico publicado en 2015

Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patients

artículo científico publicado en 2004

Development of an Interactive Decision Aid for Female BRCA1/BRCA2 Carriers

artículo científico publicado en 2003

Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)

scientific article published on 19 December 2019

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.

artículo científico publicado en 2014

Does prophylactic surgery reduce the risk of gynecologic cancers arising from the Lynch syndrome?

artículo científico publicado en 2006

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials

artículo científico publicado en 2017

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

artículo científico publicado en 2020

Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations

article by Lori J Pierce et al published 1 October 2000 in Journal of Clinical Oncology

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

article by Timothy R. Rebbeck et al published November 2005 in Journal of Clinical Oncology

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers

artículo científico publicado en 2005

Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65

artículo científico publicado en 2017

Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint

scholarly article published in NPJ breast cancer

Estrogen metabolism and risk of breast cancer in postmenopausal women.

artículo científico publicado en 2012

Evaluation and management of women with BRCA1/2 mutations.

artículo científico publicado en 2005

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2017

Evaluation of a virtual dialogue method for breast cancer patient education

artículo científico publicado en 2009

Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers

scientific article published on February 2017

Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis

artículo científico publicado en 2010

Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2014

Exemestane Use in Postmenopausal Women at High Risk for Invasive Breast Cancer: Evaluating Biomarkers of Efficacy and Safety

artículo científico publicado en 2016

Extended Adjuvant Endocrine Therapy for Postmenopausal Women: Treating Many to Benefit a Few.

artículo científico publicado en 2018

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2016

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

article

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

artículo científico publicado en 2020

Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

artículo científico publicado en 2012

Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.

artículo científico publicado en 2014

Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).

artículo científico publicado en 2017

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

artículo científico publicado en 2016

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

artículo científico publicado en 2021

Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).

artículo científico publicado en 2009

Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221).

artículo científico publicado en 2011

Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations

scientific article published on 01 July 2019

Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers

artículo científico publicado en 2011

Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers

artículo científico publicado en 2009

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

article

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

scientific article published on 18 May 2020

Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci

artículo científico publicado en 2018

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

artículo científico publicado en 2019

Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

artículo científico publicado en 2005

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers

artículo científico publicado en 2008

Hot flushes

artículo científico publicado en 2002

How Far Do We Go With Genetic Evaluation? Gene, Panel, and Tumor Testing.

artículo científico publicado en 2016

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

artículo científico publicado en 2017

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

artículo científico publicado en 2016

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

artículo científico publicado en 2016

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

artículo científico publicado en 2017

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients

artículo científico publicado en 2004

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample

artículo científico publicado en 2002

Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy

artículo científico publicado en 2016

Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population

artículo científico publicado en 2017

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

artículo científico publicado en 2016

Initiation of Trastuzumab by Women Younger Than 64 Years for Adjuvant Treatment of Stage I-III Breast Cancer

artículo científico publicado en 2017

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium

artículo científico publicado en 2011

Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status

artículo científico publicado en 2011

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance

artículo científico publicado en 2011

Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice

artículo científico publicado en 2012

Long-term risk of medical conditions associated with breast cancer treatment

artículo científico publicado en 2014

Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers

artículo científico publicado en 2014

Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).

artículo científico publicado en 2016

Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer

artículo científico publicado en 2004

Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

artículo científico publicado en 2010

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial

artículo científico publicado en 2019

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.

artículo científico publicado en 2016

Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer

scientific article published on 11 July 2020

Management of women at increased risk for hereditary breast cancer.

artículo científico publicado en 2006

Management updates for women with a BRCA1 or BRCA2 mutation

artículo científico publicado en 2007

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

scientific article published on 19 June 2019

Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes

artículo científico publicado en 2011

Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers

artículo científico publicado en 2009

Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3.

artículo científico publicado en 2016

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

artículo científico publicado en 2006

Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives

scientific article published on 21 August 2018

Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations

artículo científico publicado en 2018

Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationship.

artículo científico publicado en 2013

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

artículo científico publicado en 2015

Novel molecular prognostic markers in breast cancer

artículo científico publicado en 2009

Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers

artículo científico publicado en 2010

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2002

PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer.

artículo científico publicado en 2018

PLAC1 as a serum biomarker for breast cancer

artículo científico publicado en 2018

Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial

artículo científico publicado en 2005

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

artículo científico publicado en 2011

Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling

artículo científico publicado en 2015

Patient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901.

artículo científico publicado en 2012

Patterns of 21-gene assay testing and chemotherapy use in black and white breast cancer patients

scientific article published on December 2014

Perceived risk of breast cancer among Latinas attending community clinics: risk comprehension and relationship with mammography adherence.

artículo científico publicado en 2008

Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer ⬇️

artículo científico publicado el 26 de octubre de 2010

Physical activity before, during and after chemotherapy for high-risk breast cancer: relationships with survival

scientific article published on 02 April 2020

Physical and psychological health in rare cancer survivors

artículo científico publicado en 2016

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

artículo científico publicado en 2020

Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies

artículo científico publicado en 2016

Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time.

artículo científico publicado en 2016

Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years

artículo científico publicado en 2015

Practical aspects of delivering hereditary cancer risk counseling

artículo científico publicado en 2007

Prediction of benefit from adjuvant treatment in patients with breast cancer

scientific article published on January 2010

Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status

artículo científico publicado en 2012

Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors

artículo científico publicado en 2006

Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients

scientific article published on 01 January 2020

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group

artículo científico publicado en 2008

Predictors of enrollment into a familial cancer registry by individuals at high risk for BRCA1/2

artículo científico publicado en 2007

Predictors of genetic testing uptake in newly diagnosed breast cancer patients

artículo científico publicado en 2020

Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer

scientific article published on 10 November 2018

Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data.

artículo científico publicado en 2014

Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors

scientific article published on 23 November 2018

Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types

scientific article published on 23 July 2018

Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.

artículo científico publicado en 2009

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

artículo científico publicado en 2002

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

artículo científico publicado en 2012

Providers' perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American women

artículo científico publicado en 2011

Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS.

artículo científico publicado en 2012

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

scientific article published on 23 September 2019

Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing

scientific article published on 11 December 2006

RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies

artículo científico publicado en 2007

Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up

artículo científico publicado en 2017

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.

scientific article published on 21 January 2014

Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction

artículo científico publicado en 2009

Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.

artículo científico publicado en 2018

Rapid progression of prostate cancer in men with a BRCA2 mutation

artículo científico publicado en 2008

Re: Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative

scientific article published on 01 August 2019

Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score

artículo científico publicado en 2019

Results from Four Rounds of Ovarian Cancer Screening in a Randomized Trial

Results from four rounds of ovarian cancer screening in a randomized trial

artículo científico publicado en 2009

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study

artículo científico publicado en 2008

SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function.

artículo científico publicado en 2017

SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer

artículo científico publicado en 2014

Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

artículo científico

Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.

artículo científico publicado en 2006

Shared heritability and functional enrichment across six solid cancers

artículo científico publicado en 2019

Shared heritability and functional enrichment across six solid cancers

Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer

artículo científico publicado en 2019

Simulation of Chemotherapy Effects in Older Breast Cancer Patients With High Recurrence Scores

scientific article published on 15 October 2019

Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype

scientific article published on 25 September 2019

Smoking and the risk of breast cancer among carriers of BRCA mutations

article

Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update

artículo científico publicado en 2008

Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab.

artículo científico publicado en 2013

Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers

artículo científico publicado en 2006

Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.

artículo científico publicado en 2017

Supplement use during an intergroup clinical trial for breast cancer (S0221).

artículo científico publicado en 2013

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint

artículo científico publicado en 2018

Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study

artículo científico publicado en 2019

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)

artículo científico publicado en 2020

Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers

artículo científico publicado en 2009

Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians

artículo científico publicado en 2003

Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy inBRCA1/2-Associated Stage I/II Breast Cancer

artículo científico publicado en 2006

The Cancer Genetics Network: recruitment results and pilot studies

artículo científico

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

scientific article published on 01 November 2019

The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families

artículo científico publicado en 2019

The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer

artículo científico publicado en 2015

The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers

artículo científico publicado en 2006

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

artículo científico publicado en 2020

Treatment of primary breast tumors in de novo metastatic breast cancer

artículo científico publicado en 2014

Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155

artículo científico publicado en 2011

Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support

artículo científico publicado en 2016

Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations

artículo científico publicado en 2016

Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients

artículo científico publicado en 2005

Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.

artículo científico publicado en 2002

Utilizing prognostic and predictive factors in breast cancer

artículo científico publicado en 2005

Validity of models for predicting BRCA1 and BRCA2 mutations

artículo científico publicado en 2007

Venous thromboembolic disease and stroke in women taking tamoxifen for breast cancer chemoprevention

scientific article published on 01 December 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda